Abbott (NYSE: ABT) appears to be part of the trend of large companies advising their shareholders to avoid unsolicited mini-tender offers. The Abbott Park, Illinois–based maker of diagnostics, medical devices, nutritionals and branded generic medicines posted a news release today in which it advised shareholders to ignore an unsolicited mini-tender offer from TRC Capital Investment […]